ARCHIVE ISSUES – SEPTEMBER 2021

The Journal of Precision Medicine - September 2021

The Integration of Personalized Medicine into Healthcare: Advancing the Promise to More Patients

The value of adding RNA sequencing to precision biomarker strategy

As Targeted Therapies Expand Beyond Cancer, Companion Diagnostics Must Improve

Tissue-Based Multiplex Biomarker Assays and Companion Diagnostics

Improving Patient Outcomes Through the Integration of Pharmacogenomic Testing into Comprehensive Medication Management Care Models

Part 2: Industry challenges and opportunities for the integration of precision medicine tools at the point of care

The Power and the Promise: Integrating Pharmacogenomics into Clinical Practice – Designing a PGx Program That Works

The In Vitro Diagnostic Regulation in Europe: Implications for Precision Medicine and Pharmaceutical Development

A Comprehensive Genomic Landscape for Amyotrophic Lateral Sclerosis (ALS) to Support Precision Medicine Initiatives

Part 1: Surveillance of Wastewater and Prevention Platform (SWAPP): A Case Study of Digital Public Health and SARS-CoV-2

NGS and circulating markers in the clinic at UPMC

The role of UK Biobank

To what extent does Precision Medicine play a role in shaping the future diagnostics and treatment of Cystic Fibrosis?

BACK TO ARCHIVE